Skip to main content
. 2022 Jul 14;12:924354. doi: 10.3389/fonc.2022.924354

Figure 2.

Figure 2

Decitabine reduces ΔNp63 and mRNA levels in squamous cells. (A) Representative Western blots and densitometric quantitation of ΔNp63 in HaCaT, FaDu and SCC-25 cells treated with the indicated concentrations of decitabine for four days. β-actin is shown as loading control. Densitometry data represent fold change ± SEM compared to untreated cells (0, DMSO only; n = 3 for each dose in each cell line) and normalized to β-actin. (B) ΔNP63 mRNA levels normalized to ACTB mRNA (n = 3 to 5 biological replicates, each with technical triplicates). Data are shown as fold change ± SEM compared to untreated cells (0, DMSO only). *p < 0.05; **p < 0.01; ***p < 0.001 compared to control.